Royalty Pharma plc - Ordinary Shares - Class A

NASDAQ:RPRX   11:50:25 AM EDT
37.28
+0.54 (+1.47%)
Equity Financing / Related

Morphosys AG Morphosys Concludes A Us$ 100 Million Capital Increase To Implement Purchase Of 1,337,552 Shares By Royalty Pharma

Published: 07/16/2021 17:26 GMT
Royalty Pharma plc - Ordinary Shares - Class A (RPRX) - Dgap-news: Morphosys Concludes a Us$ 100 Million Capital Increase to Implement the Purchase of 1,337,552 Shares by Royalty Pharma.
Morphosys Concludes a Us$ 100 Million Capital Increase to Implement Purchase of 1,337,552 Shares by Royalty Pharma.
Royalty Pharma's Share Purchase in Aggregate Amount of Us$ 100 Million is Part of Funding Agreement With Morphosys for Now Completed Acquisition of Constellation Pharmaceuticals.